BREAST IMPLANT GLOBAL SETTLEMENT WILL BE RULED ON BY SEPT. 1
This article was originally published in The Gray Sheet
Executive SummaryBREAST IMPLANT GLOBAL SETTLEMENT WILL BE RULED ON BY SEPT. 1 after U.S District Court of Northern Alabama Judge Samuel Pointer considers whether the settlement is fair to women from other countries. After a three-day hearing, held beginning Aug. 18 in Birmingham, Pointer said Aug. 23 that he will issue a ruling by Sept. 1 on whether the silicone implant settlement is "fair, reasonable, adequate, and in the best interests of class members." Final approval of the class action case appears likely, but Pointer said that while he considers the $4.25 bil. settlement to be in the best interest of the American litigants, the question of fairness to foreign claimants caused him to delay his ruling.
You may also be interested in...
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.
India’s Hilleman Laboratories says it’s aiming to develop an affordable vaccine that will target pregnant women in low- and middle-income countries to prevent Group B Streptococcus, a potentially fatal infection passed to babies during childbirth.
Chi-Med’s surufatinib has come up trumps in a second trial in neuroendocrine tumors, after the monitoring committee recommended an early halt following achievement of its PFS target in the pancreatic setting.